MYRIAD GENETICS, INC. Calendar Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.60 USD | +2.28% |
|
+1.97% | -13.27% |
| Nov. 20 | Myriad Genetics, Inc. Announces Updates to Its Agreement with Illumina Inc | CI |
| Nov. 19 | Sintx Technologies, Inc. Appoints Gregg R. Honigblum as Chief Strategy Officer | CI |
Chart calendar Myriad Genetics, Inc.
2ad9a61a18e48.jALq1c3Lnd8X3hgd4jV0ss1KC3Lnwm8OrC3AYLHWDHg.00md5K-y0ro6k1xsu2xE3p0eR0CejhpL_kyLBdiXdjD6MLWs_-b7jya7aw~b2fb8c4bcfbe933a856e1ddd9582b6b0
Upcoming events on Myriad Genetics, Inc.
Past events on Myriad Genetics, Inc.
| 2024-11-20 03:20 pm | Wolfe Research Healthcare Conference |
| 2024-11-13 03:30 pm | Guggenheim Securities Healthcare Innovation Conference |
| 2024-11-07 04:30 pm | Q3 2024 Earnings Call |
| 2024-11-07 04:05 pm | Q3 2024 Earnings Release |
| 2024-10-09 09:00 am | Investor Day |
| 2024-09-19 01:45 pm | National Society of Genetic Counselors Conference |
| 2024-09-18 | National Society of Genetic Counselors Conference - Poster PRE348 |
| 2024-09-18 | National Society of Genetic Counselors Conference - Poster PRE344 |
| 2024-09-18 | National Society of Genetic Counselors Conference - Poster PRE324 |
| 2024-09-17 | National Society of Genetic Counselors Conference - Poster PRE351 |
| 2024-09-17 | National Society of Genetic Counselors Conference - Poster PRE349 |
| 2024-09-17 | National Society of Genetic Counselors Conference - Poster PRE347 |
| 2024-09-17 | National Society of Genetic Counselors Conference - Poster PRE333 |
| 2024-09-17 | National Society of Genetic Counselors Conference - Poster PRE323 |
| 2024-09-17 | National Society of Genetic Counselors Conference - Poster CAN91 |
| 2024-09-05 07:00 am | Morgan Stanley Healthcare Conference |
| 2024-09-04 01:30 pm | Wells Fargo Healthcare Conference |
| 2024-08-06 04:30 pm | Q2 2024 Earnings Call |
| 2024-08-06 04:05 pm | Q2 2024 Earnings Release |
| 2024-06-12 03:20 pm | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 691 687 0.52% | 678 670 1.24% | 753 751 0.27% | 841 | 885 | 975 |
|
EBITDA Million USD | Released Forecast Spread | 71,9 74,0 -2.9% | -21,0 -20,4 -3.15% | -6,30 -12,8 50.6% | 36,3 | 36,9 | 72,6 |
|
EBIT Million USD | Released Forecast Spread | 9,10 5,67 60.51% | -32,8 -34,7 5.51% | -25,5 -29,7 14.13% | 19,7 | 14,7 | 53,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -57,1 -41,2 -38.59% | -141 -131 -7.34% | -262 -263 0.17% | -105 | -57,8 | -9,92 |
|
Net income Million USD | Released Forecast Spread | -27,2 -100 72.89% | -112 -105 -6.26% | -263 -256 -2.7% | -106 | -72,0 | -11,7 |
|
EPS USD | Released Forecast Spread | -0,35 -0,46 23.91% | -1,39 -1,32 -5.04% | -3,18 -3,13 -1.68% | -1,17 | -0,79 | -0,13 |
| Announcement Date | 24/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 181 172 5.62% | 184 187 -1.8% | 192 179 7.15% | 197 195 1.01% | 202 193 4.63% | 212 205 3.17% | 213 211 1.19% | 214 | 213 | 222 | 222 | 228 | 230 | 240 | 243 |
|
EBITDA Million USD | Released Forecast Spread | -20,5 -18,0 -13.89% | -4,20 -5,25 20% | 1,20 -3,50 134.29% | 10,1 5,25 92.38% | 4,40 -5,55 179.28% | 11,9 3,17 274.89% | 14,1 8,06 74.85% | 7,38 | 6,47 | 10,9 | 10,1 | 12,0 | |||
|
EBIT Million USD | Released Forecast Spread | -21,9 -20,0 -9.4% | -6,80 -8,68 21.67% | -2,20 -7,64 71.2% | 5,70 1,20 375.56% | -0,60 -12,2 95.08% | 7,40 -0,98 855.64% | 9,50 2,48 283.41% | 3,33 | 1,50 | 6,13 | 6,10 | 7,30 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,6 -49,3 -6.71% | -116 -37,0 -213.6% | -61,2 -35,9 -70.6% | -32,3 -30,5 -5.85% | -25,9 -34,2 24.27% | -37,2 -23,9 -55.42% | -21,2 -24,0 11.61% | -20,5 | -19,2 | -15,3 | -12,7 | -10,6 | -6,62 | -2,86 | -2,09 |
|
Net income Million USD | Released Forecast Spread | -54,7 -38,7 -41.45% | -116 -34,6 -235.17% | -61,3 -31,8 -93.06% | -31,2 -24,5 -27.52% | -26,0 -31,4 17.15% | -36,7 -24,3 -50.87% | -22,1 -23,8 7.08% | -20,8 | -19,2 | -15,2 | -13,1 | -11,0 | -6,82 | -2,91 | -2,79 |
|
EPS USD | Released Forecast Spread | -0,67 -0,42 -60.8% | -1,42 -0,36 -290.83% | -0,75 -0,33 -127.27% | -0,36 -0,29 -23.08% | -0,29 -0,30 4.13% | -0,41 -0,24 -73.73% | -0,24 -0,23 -6.19% | -0,20 | -0,21 | -0,16 | -0,14 | -0,12 | -0,08 | -0,04 | -0,03 |
| Announcement Date | 03/05/23 | 03/08/23 | 06/11/23 | 27/02/24 | 07/05/24 | 06/08/24 | 07/11/24 | - | - | - | - | - | - | - | - |
| 2025-01-30 02:00 am | VITROLIFE AB: Q4 2024 Earnings Release |
| 2025-02-11 | 10X GENOMICS, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-19 | LANTHEUS HOLDINGS, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-19 | GUARDANT HEALTH, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-03-03 | CASTLE BIOSCIENCES, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-03-03 | MYRIAD GENETICS, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-03-07 01:00 am | BIOMÉRIEUX: Q4 2024 Earnings Release |
| 2025-03-11 | DIASORIN S.P.A.: Q4 2024 Earnings Release (Projected) |
| 2025-03-16 | NEW HORIZON HEALTH LIMITED: Q4 2024 Earnings Release (Projected) |
| 2025-03-24 | SD BIOSENSOR, INC: Q4 2024 Earnings Release (Projected) |
Past sector events for Myriad Genetics, Inc.
| 2024-11-12 | SD BIOSENSOR, INC: Q3 2024 Earnings Release |
| 2024-11-07 04:05 pm | MYRIAD GENETICS, INC.: Q3 2024 Earnings Release |
| 2024-11-06 04:05 pm | GUARDANT HEALTH, INC.: Q3 2024 Earnings Release |
| 2024-11-06 07:00 am | LANTHEUS HOLDINGS, INC.: Q3 2024 Earnings Release |
| 2024-11-04 | DIASORIN S.P.A.: Q3 2024 Earnings Release |
| 2024-11-04 04:50 pm | CASTLE BIOSCIENCES, INC.: Q3 2024 Earnings Release |
| 2024-10-30 | ZHEJIANG ORIENT GENE BIOTECH CO., LTD: Q3 2024 Earnings Release |
| 2024-10-30 | GETEIN BIOTECH, INC: Q3 2024 Earnings Release |
| 2024-10-30 | HANGZHOU ALLTEST BIOTECH CO., LTD.: Q3 2024 Earnings Release |
| 2024-10-30 | ASSURE TECH (HANGZHOU) CO., LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MYGN Stock
- Calendar Myriad Genetics, Inc.